Espey Mfg. & Electronics (ESP) 10-Q 12 Feb 25 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Dec. 31, 2024	Feb. 10, 2025
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Entity Information [Line Items]
Entity Registrant Name	ESPEY MFG. & ELECTRONICS CORP.
Entity Central Index Key	0000033533
Entity File Number	1-4383
Entity Tax Identification Number	14-1387171
Entity Incorporation, State or Country Code	NY
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	233 Ballston Avenue
Entity Address, City or Town	Saratoga Springs
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	12866
Entity Phone Fax Numbers [Line Items]
City Area Code	518
Local Phone Number	245-4400
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock $.33-1/3 par value
Trading Symbol	ESP
Security Exchange Name	NYSEAMER
Entity Common Stock, Shares Outstanding		2,796,758

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2024	Jun. 30, 2024
ASSETS
Cash and cash equivalents	$ 8,027,478	$ 4,351,970
Investment securities	20,264,567	18,878,631
Trade accounts receivable, less allowance for credit losses of $3,000	6,993,840	6,635,490
Inventories:
Raw materials	1,813,168	1,693,448
Work-in-process	689,757	1,645,973
Costs related to contracts in process	15,109,021	15,904,588
Total inventories	17,611,946	19,244,009
Net deferred tax assets	864,449	895,154
Prepaid expenses and other current assets	1,793,934	3,231,402
Total current assets	55,556,214	53,236,656
Property, plant and equipment, net	4,635,071	3,306,275
Total assets	60,191,285	56,542,931
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	2,662,701	3,751,209
Accrued expenses:
Salaries and wages	502,295	928,163
Vacation	534,025	511,144
ESOP payable	180,518
Other	1,284,491	757,552
Payroll and other taxes withheld	837	56,862
Contract liabilities	9,875,627	9,043,422
Income taxes payable	334,146	220,607
Total current liabilities	15,374,640	15,268,959
Total liabilities	15,374,640	15,268,959
Commitments and contingencies (See Note 5)
Authorized 10,000,000 shares; Issued 3,129,874 shares as of December 31, 2024 and June 30, 2024. Outstanding 2,796,758 and 2,733,958 shares as of December 31, 2024 and June 30, 2024, respectively (includes 200,652 and 211,487 Unearned ESOP shares, respectively)	1,043,291	1,043,291
Capital in excess of par value	24,851,718	23,930,428
Accumulated other comprehensive gain	5,004	6,544
Retained earnings	28,232,545	26,004,790
Total stockholders equity before ESOP	54,132,558	50,985,053
Less: Unearned ESOP shares	(3,868,093)	(3,868,093)
Cost of 333,116 and 395,916 shares of common stock in treasury as of December 31, 2024 and June 30, 2024, respectively	(5,447,820)	(5,842,988)
Total stockholders’ equity	44,816,645	41,273,972
Total liabilities and stockholders' equity	$ 60,191,285	$ 56,542,931

Balance Sheets (Parentheticals)

Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Statement of Financial Position [Abstract]
Trade accounts receivable, allowance (in Dollars)	$ 3,000	$ 3,000
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	3,129,874	3,129,874
Common stock, shares outstanding	2,796,758	2,733,958
Unearned ESOP shares	200,652	211,487
Common stock, par value (in Dollars per share)	$ 0.33	$ 0.33
Treasury stock, shares	333,116	395,916

Statements of Comprehensive Inc

Statements of Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 13,608,740	$ 10,302,541	$ 24,051,958	$ 18,870,755
Cost of sales	10,445,028	7,159,966	18,087,364	13,482,803
Gross profit	3,163,712	3,142,575	5,964,594	5,387,952
Selling, general and administrative expenses	1,139,275	1,049,690	2,220,944	2,073,371
Operating income	2,024,437	2,092,885	3,743,650	3,314,581
Other income
Interest income	260,222	161,513	527,839	308,943
Other	8,203	5,251	18,994	19,394
Total other income	268,425	166,764	546,833	328,337
Income before provision for income taxes	2,292,862	2,259,649	4,290,483	3,642,918
Provision for income taxes	384,363	464,279	783,667	753,004
Net income	1,908,499	1,795,370	3,506,816	2,889,914
Other comprehensive income, net of tax:
Unrealized (loss) gain on investment securities	(9,232)	3,622	(1,540)	5,417
Total comprehensive income	$ 1,899,267	$ 1,798,992	$ 3,505,276	$ 2,895,331
Net income per share:
Basic (in Dollars per share)	$ 0.74	$ 0.73	$ 1.37	$ 1.17
Diluted (in Dollars per share)	$ 0.71	$ 0.72	$ 1.32	$ 1.16
Weighted average number of shares outstanding:
Basic (in Shares)	2,583,307	2,478,588	2,554,622	2,474,340
Diluted (in Shares)	2,707,542	2,499,210	2,653,890	2,492,499
Dividends per share: (in Dollars per share)	$ 0.25	$ 0.15	$ 0.5	$ 0.3

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock	Capital in Excess of Par Value	Accumulated Other Comprehensive Gain	Retained Earnings	Treasury Stock	Unearned ESOP Shares	Total
Balance at Jun. 30, 2023	$ 1,043,291	$ 23,283,245	$ (2,429)	$ 21,867,720	$ (6,038,691)	$ (4,273,378)	$ 35,879,758
Balance (in Shares) at Jun. 30, 2023	2,702,633				427,241
Net income				2,889,914			2,889,914
Other comprehensive income (loss), net of tax			5,417				5,417
Total comprehensive income							2,895,331
Stock options exercised		34,490			$ 24,990		59,480
Stock options exercised (in Shares)	4,000				(4,000)
Stock-based compensation		131,155					131,155
Dividends paid on common stock, per share				(741,895)			(741,895)
Balance at Dec. 31, 2023	$ 1,043,291	23,448,890	2,988	24,015,739	$ (6,013,701)	(4,273,378)	38,223,829
Balance (in Shares) at Dec. 31, 2023	2,706,633				423,241
Balance at Sep. 30, 2023	$ 1,043,291	23,373,388	(634)	22,591,316	$ (6,013,701)	(4,273,378)	36,720,282
Balance (in Shares) at Sep. 30, 2023	2,706,633				423,241
Net income				1,795,370			1,795,370
Other comprehensive income (loss), net of tax			3,622				3,622
Total comprehensive income							1,798,992
Stock-based compensation		75,502					75,502
Dividends paid on common stock, per share				(370,947)			(370,947)
Balance at Dec. 31, 2023	$ 1,043,291	23,448,890	2,988	24,015,739	$ (6,013,701)	(4,273,378)	38,223,829
Balance (in Shares) at Dec. 31, 2023	2,706,633				423,241
Balance at Jun. 30, 2024	$ 1,043,291	23,930,428	6,544	26,004,790	$ (5,842,988)	(3,868,093)	$ 41,273,972
Balance (in Shares) at Jun. 30, 2024	2,733,958				395,916		2,733,958
Net income				3,506,816			$ 3,506,816
Other comprehensive income (loss), net of tax			(1,540)				(1,540)
Total comprehensive income							3,505,276
Stock options exercised		728,257			$ 395,168		1,123,425
Stock options exercised (in Shares)	62,800				(62,800)
Stock-based compensation		193,033					193,033
Dividends paid on common stock, per share				(1,279,061)			(1,279,061)
Balance at Dec. 31, 2024	$ 1,043,291	24,851,718	5,004	28,232,545	$ (5,447,820)	(3,868,093)	$ 44,816,645
Balance (in Shares) at Dec. 31, 2024	2,796,758				333,116		2,796,758
Balance at Sep. 30, 2024	$ 1,043,291	24,111,147	14,236	26,969,864	$ (5,777,389)	(3,868,093)	$ 42,493,056
Balance (in Shares) at Sep. 30, 2024	2,744,458				385,416
Net income				1,908,499			1,908,499
Other comprehensive income (loss), net of tax			(9,232)				(9,232)
Total comprehensive income							1,899,267
Stock options exercised		649,030			$ 329,569		978,599
Stock options exercised (in Shares)	52,300				(52,300)
Stock-based compensation		91,541					91,541
Dividends paid on common stock, per share				(645,818)			(645,818)
Balance at Dec. 31, 2024	$ 1,043,291	$ 24,851,718	$ 5,004	$ 28,232,545	$ (5,447,820)	$ (3,868,093)	$ 44,816,645
Balance (in Shares) at Dec. 31, 2024	2,796,758				333,116		2,796,758

Statements of Changes in Stoc_2

Statements of Changes in Stockholders' Equity (Unaudited) (Parentheticals) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]
Other comprehensive income (loss), net of tax	$ (1,939)	$ 761	$ (323)	$ 1,138
Dividends paid on common stock per share	$ 0.25	$ 0.15	$ 0.5	$ 0.3

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows from Operating Activities:
Net income	$ 3,506,816	$ 2,889,914
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	193,033	131,155
Depreciation	219,126	233,526
ESOP compensation expense	286,262	183,364
Deferred income tax benefit	30,705	(212,848)
Gain on disposal of property, plant and equipment		(150)
Changes in assets and liabilities:
Increase in trade accounts receivable	(358,350)	(205,985)
Decrease in income taxes receivable		35,666
Decrease in inventories	1,632,063	2,027,322
Decrease in prepaid expenses and other current assets	1,437,468	385,089
(Decrease) increase in accounts payable	(1,088,509)	892,011
Decrease in accrued salaries and wages	(425,868)	(382,530)
Increase (decrease) in vacation accrual	22,881	(163,645)
Decrease in ESOP payable	(105,744)	(70,093)
Increase in other accrued expenses	526,939	436,356
Decrease in payroll and other taxes withheld	(56,025)	(11,786)
Increase (decrease) in contract liabilities	832,205	(457,836)
Increase in income taxes payable	113,539	229,625
Net cash provided by operating activities	6,766,541	5,939,155
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(1,547,922)	(3,469,630)
Proceeds from grant award		968,722
Proceeds from sale of property, plant and equipment		150
Purchase of investment securities	(14,007,475)	(13,410,242)
Proceeds from sale/maturity of investment securities	12,620,000	11,508,438
Net cash used in investing activities	(2,935,397)	(4,402,562)
Cash Flows from Financing Activities:
Dividends on common stock	(1,279,061)	(741,895)
Proceeds from exercise of stock options	1,123,425	59,480
Net cash used in financing activities	(155,636)	(682,415)
Increase in cash and cash equivalents	3,675,508	854,178
Cash and cash equivalents, beginning of period	4,351,970	2,748,755
Cash and cash equivalents, end of period	8,027,478	3,602,933
Supplemental Schedule of Cash Flow Information:
Income taxes paid	$ 639,014	$ 702,000

Basis of Presentation

Basis of Presentation	6 Months Ended
	Dec. 31, 2024
Basis of Presentation [Abstract]
Basis of Presentation	Note 1. Basis of Presentation In the opinion of management the accompanying unaudited financial statements contain all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the results for such periods. The results for any interim period are not necessarily indicative of the results to be expected for the full fiscal year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition, inventories, income taxes, and stock-based compensation. Specific to inventories, including work-in-process and contracts in process, management evaluates, quarterly, those estimates used in determining the cost to complete for each contract on Espey Mfg. & Electronics Corp.’s (the “Company”) sales backlog. The change in estimates may affect the reported amount of inventories and gross profit in the current or a future period and could result in the Company recording a loss contingency when a loss is determined to be probable and reasonably estimated. Management bases its estimates on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. These financial statements should be read in conjunction with the Company's most recent audited financial statements included in its report on Form 10-K for the year ended June 30, 2024. Certain reclassifications may have been made to the prior year financial statements to conform to the current year presentation.

Investment Securities

Investment Securities	6 Months Ended
	Dec. 31, 2024
Investment Securities [Abstract]
Investment Securities	Note 2. Investment Securities FASB Accounting Standards Codification (“ASC”) 820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: ▪ Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. ▪ Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. ▪ Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The carrying amounts of financial instruments, including cash and cash equivalents, short term investments, accounts receivable, accounts payable and accrued expenses, approximated fair value as of December 31, 2024 and June 30, 2024 because of the immediate or short-term maturity of these financial instruments. Investment securities at December 31, 2024 and June 30, 2024 consisted of certificates of deposit, municipal bonds and U.S. Treasury bills. The Company classifies investment securities as available-for-sale which have been determined to be level 1 assets. The cost, gross unrealized gains, gross unrealized losses and fair value of available-for-sale debt securities by major security type at December 31, 2024 and June 30, 2024 are as follows: Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value December 31, 2024 Certificates of deposit $ 19,028,000 $ — $ — $ 19,028,000 Municipal bonds 1,134,476 5,797 (3,459 ) 1,136,814 U.S. Treasury bills 95,756 3,997 — 99,753 Total investment securities $ 20,258,232 $ 9,794 $ (3,459 ) $ 20,264,567 June 30, 2024 Certificates of deposit $ 17,651,000 $ — $ — $ 17,651,000 Municipal bonds 709,059 5,824 (3,313 ) 711,570 U.S. Treasury bills 510,288 5,773 — 516,061 Total investment securities $ 18,870,347 $ 11,597 $ (3,313 ) $ 18,878,631 The portfolio is diversified and highly liquid and primarily consists of investment grade fixed income instruments. At December 31, 2024, the Company did not have any investments in individual securities that have been in a continuous loss position considered to be other than temporary. As of December 31, 2024 and June 30, 2024, the remaining contractual maturities of available-for-sale debt securities were as follows: Years to Maturity Less than One to One Year Five Years Total December 31, 2024 Available-for-sale $ 18,116,028 $ 2,148,539 $ 20,264,567 June 30, 2024 Available-for-sale $ 17,889,582 $ 989,049 $ 18,878,631

Net Income Per Share

Net Income Per Share	6 Months Ended
	Dec. 31, 2024
Net Income Per Share [Abstract]
Net Income per Share	Note 3. Net Income per Share Basic net income per share excludes dilution and is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the Company. The computation of diluted net income per share excluded options to purchase 0 shares of our common stock for the three and six months ended December 31, 2024 and 149,531 shares for the three and six months ended December 31, 2023, as the effect of including them would be anti-dilutive. As unearned shares owned by the Company’s sponsored leveraged employee stock ownership plan (the “ESOP”) are released or committed-to-be-released, the shares become outstanding for earnings-per-share computations. The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the six month periods ended December 31: 2024 2023 Numerator: Net income $ 3,506,816 $ 2,889,914 Denominator: Basic EPS: Common shares outstanding, beginning of period 2,733,958 2,702,633 Unearned ESOP shares (211,487 ) (233,646 ) Weighted average common shares issued during the period 29,384 2,523 Weighted average ESOP shares earned during the period 2,767 2,830 Denominator for basic earnings per common shares – Weighted average common shares 2,554,622 2,474,340 Diluted EPS: Common shares outstanding, beginning of period 2,733,958 2,702,633 Unearned ESOP shares (211,487 ) (233,646 ) Weighted average common shares issued during the period 29,384 2,523 Weighted average ESOP shares earned during the period 2,767 2,830 Weighted average dilutive effect of stock options 99,268 18,159 Denominator for diluted earnings per common shares – Weighted average common shares 2,653,890 2,492,499

Stock Based Compensation

Stock Based Compensation	6 Months Ended
	Dec. 31, 2024
Stock Based Compensation [Abstract]
Stock Based Compensation	Note 4. Stock Based Compensation The Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans. Total stock-based compensation expense recognized in the statements of comprehensive income for the three-month periods ended December 31, 2024 and 2023 was $91,541 and $75,502, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSOs”) for the three-month periods ended December 31, 2024 and 2023 was $8,362 and $10,290, respectively. The deferred tax benefit related to the NQSOs as of December 31, 2024 and 2023 was approximately $1,756 and $2,161, respectively. Total stock-based compensation expense recognized in the statements of comprehensive income for the six-month periods ended December 31, 2024 and 2023 was $193,033 and $131,155, respectively, before income taxes. The amount of this stock-based compensation expense related to NQSOs for the six-month periods ended December 31, 2024 and 2023 was $15,421 and $18,545, respectively. The deferred tax benefit related to the NQSOs as of December 31, 2024 and 2023 was approximately $3,238 and $3,894, respectively. The remaining stock option expense in each year related to incentive stock options (“ISOs”) which are not deductible by the Company when exercised, assuming a qualifying disposition and as such no deferred tax benefit was established related to these amounts. As of December 31, 2024, there was $423,041 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 1.75 years, of which $385,833 relates to ISOs and $37,208 relates to NQSOs. The total deferred tax benefit related to these awards is expected to be $7,814. The Company has one employee stock option plan under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"). The Board of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market value of the common stock on the date of grant. The maximum aggregate number of shares of Common Stock subject to options or awards to non-employee directors is 133,000 and the maximum aggregate number of shares of Common Stock subject to options or awards granted to non-employee directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed 15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of December 31, 2024, options covering 87,375 shares have been exercised and options covering 307,656 shares are outstanding. Options covering 4,969 shares remain available for grant after factoring the cancelled shares, which are eligible to be re-granted. While no further grants of options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of December 31, 2024, 27,600 options were outstanding under such plan of which all are vested and exercisable. ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for dividend yield, volatility, expected life and interest rates. The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the six months ended December 31, 2024 and 2023. December 31, 2024 December 31, 2023 Dividend yield 3.79% 3.63% Company’s expected volatility 33.33% 31.20% Risk-free interest rate 4.35% 4.39% Expected term 5.1 yrs 5.3 yrs Weighted average fair value per share of options granted during the period $ 5.40 $ 4.03 The Company declared and paid regular cash dividends of $0.50 per share for the six months ended December 31, 2024 and paid $0.30 cash dividends for the six months ended December 31, 2023. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience. The following table summarizes stock option activity during the six months ended December 31, 2024: Employee Stock Option Plans Weighted Number of Weighted Average Shares Average Remaining Aggregate Subject Exercise Contractual Intrinsic to Option Price Term Value Balance at July 1, 2024 322,056 $ 18.41 6.59 Granted 76,500 $ 21.58 9.52 Exercised (62,800 ) $ 17.89 — Forfeited or expired (500 ) $ 16.54 — Outstanding at December 31, 2024 335,256 $ 19.23 6.95 $ 3,661,427 Vested or expected to vest at December 31, 2024 320,083 $ 19.19 6.84 $ 3,507,361 Exercisable at December 31, 2024 180,356 $ 19.26 5.09 $ 1,964,248 The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE American on December 31, 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on December 31, 2024. This amount changes based on the fair market value of the Company’s common stock. The intrinsic value of options exercised during the six months ended December 31, 2024 and 2023 was $668,878 and $9,482, respectively. The following table summarizes changes in non-vested stock options during the six months ended December 31, 2024: Weighted Number Average of Shares Grant Date Subject Fair Value to Option (per Option) Non-vested at July 1, 2024 147,300 $ 4.15 Granted 76,500 $ 5.40 Vested (68,400 ) $ 4.11 Forfeited or expired (500 ) $ 4.03 Non-vested at December 31, 2024 154,900 $ 4.78

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Dec. 31, 2024
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 5. Commitments and Contingencies The Company from time to time, enters into standby letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at December 31, 2024 and June 30, 2024. The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction may result in debarment from eligibility for awards. The government may, in certain cases, also terminate existing contracts, recover damages, and impose other sanctions and penalties. As a result of contract audits, the Company will determine a range of possible outcomes and, in accordance with ASC 450 “Contingencies,” the Company will accrue amounts within a range that appears to be its best estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information. We are party to various litigation matters and claims arising from time to time in the ordinary course of business. There are no pending litigation matters or claims which we believe will have a material adverse effect on our business, financial condition, results of operations or cash flows. The Company was awarded $7.4 million in funding during the second quarter of fiscal year 2023 in support of facility and capital equipment upgrades for testing and qualification for the United States Navy. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. The work is being conducted on the Company’s property in Saratoga Springs, NY, with completion slated for the first quarter of calendar year 2025. The Company expects to be paid within 30 days after the submission of three milestone invoices, but will not be paid for expenses incurred in excess of the specified milestone payment limits. The Company will record the receipt of milestone payments received as a reduction from the cost of the assets. The Company will have an initial cash outlay to satisfy income tax obligations arising from the value of the milestone payments received. The cash outlay arising from federal income tax obligations is expected to be recaptured in future periods. Until recaptured, estimated tax obligations associated with the receipt of milestone payments are recorded on the balance sheet and included in deferred tax assets. As of December 31, 2024, net deferred tax assets include a deferred tax asset of $888,032 associated with milestone reimbursements received totaling $4,228,722. Included in property, plant, and equipment at December 31, 2024 was $2,311,788 not yet reimbursed for facility and capital upgrades under the funding award, compared to $965,392 in spending not yet reimbursed included in property, plant, and equipment at June 30, 2024. Included in accounts payable at December 31, 2024 was approximately $11,770 for facility and capital upgrades eligible to be reimbursed under the funding award compared to $272,560 included in accounts payable at June 30, 2024. In June 2024, the Company notified the third-party administrator of the IBEW Local 1799 Pension Fund of its intention to withdraw permanently from the plan. As required by the Employee Retirement Income Security Act “ERISA”, the Company is subject to a termination withdrawal liability. The recorded termination withdrawal obligation at December 31, 2024 and June 30, 2024 totaled $561,852 and $772,157, respectively, shown within the accounts payable balance on the Company’s balance sheets. The remaining liability of $561,852 is expected to be paid in the second half of fiscal 2025. As the Company was the only remaining contributing employer to the multiemployer pension plan, its withdrawal constitutes a mass withdrawal termination. Final withdrawal calculations are contingent upon the availability of January 1, 2025 assets and the finalization of December 31, 2024 liabilities as the withdrawal liability will need to be re-determined based on a December 31, 2024 measurement date. The Company does not expect future adjustments to the established liability to have a material impact on the Company’s financial statements. The cost of the withdrawal liability obligation is recorded in indirect overhead product costs, capitalized in inventory and expensed through cost of sales based on shipments. In December 2024, the Company was awarded $3.4 million in funding in support of facility and capital equipment upgrades. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. The grant is expected to be in force through calendar year 2026. There are currently no expenditures or amounts that are considered reimbursable under this grant.

Revenue

Revenue	6 Months Ended
	Dec. 31, 2024
Revenue [Abstract]
Revenue	Note 6. Revenue The Company follows ASC 606 “Revenue from Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues. Revenue is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those products or services. Significant judgment is required in determining the satisfaction of performance obligations. Revenues from our performance obligations are satisfied over time using the output method which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point. Revenue is recognized when, or as, the customer takes control of the product or services. The output method best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred to the customer at the shipping point, as the Company has a present right to payment, the customer has legal title to the asset, the customer has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset. Total revenue recognized for the three and six months ended December 31, 2024 based on units delivered was $9,237,688 and $17,500,184, respectively, compared to $8,237,156 and $14,642,694 for the same period in fiscal year 2024. Total revenue recognized for the three and six months ended December 31, 2024 based on milestones achieved was $4,371,052 and $6,551,774, respectively, compared to $2,065,385 and $4,228,061 for the same period in fiscal year 2024. The Company offers a standard one-year product warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means the warranty only guarantees that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation. The impact of variable consideration has been considered but none identified which would be required to be allocated to the transaction price as of December 31, 2024. Our payment terms are generally 30-60 days. Contract liabilities were $9,875,627 and $9,043,422 as of December 31, 2024 and June 30, 2024, respectively. The increase in contract liabilities is primarily due to the advance collection of cash on specific contracts, offset in part, by revenue recognized. Revenue recognized that was in contract liabilities in the beginning of the fiscal year was $2,377,108 for the six months ended December 31, 2024. The Company used the practical expedient to expense incremental costs incurred to obtain a contract when the contract term is less than one year. The Company’s backlog at December 31, 2024 totaling approximately $120.1 million is currently estimated to be recognized in the following fiscal years: 16.6% in 2025; 37.4% in 2026; 7.6% in 2027, and 38.4% thereafter. The timing of supplier deliveries of material, production schedules, the completion of engineering deliverables, among other factors, could cause these estimates to change.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	6 Months Ended
	Dec. 31, 2024
Recently Issued Accounting Standards [Abstract]
Recently Issued Accounting Standards	Note 7. Recently Issued Accounting Standards Recent Accounting Pronouncements Not Yet Adopted In December 2023, FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 provide improvements primarily related to the rate reconciliation and income taxes paid information included in income tax disclosures. The Company would be required to disclose additional information regarding reconciling items equal to or greater than five percent of the amount computed by multiplying pretax income (loss) by the applicable statutory tax rate. Similarly, the Company would be required to disclose income taxes paid (net of refunds received) equal to or greater than five percent of total income taxes paid (net of refunds received). The amendments in ASU 2023-09 are effective for the annual period beginning July 1, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company will evaluate the impact of ASU 2023-09 on its financial statements. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. The adoption of ASU 2023-07 is not expected to have a significant impact on the financial statements. The Company is currently evaluating the impact of this new guidance on its financial statements. Recent Accounting Pronouncements Adopted None

Employee Stock Ownership Plan

Employee Stock Ownership Plan	6 Months Ended
	Dec. 31, 2024
Employee Stock Ownership Plan [Abstract]
Employee Stock Ownership Plan	Note 8. Employee Stock Ownership Plan The Company sponsors a leveraged employee stock ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30. The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received by the ESOP. All dividends on unallocated shares received by the ESOP are used to pay debt service. Dividends on allocated ESOP shares are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40. Accordingly, the shares purchased by the ESOP are reported as Unearned ESOP shares in the balance sheets and the statements of changes in stockholders’ equity. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. ESOP compensation expense was $163,067 and $94,175 for the three-month periods ended December 31, 2024 and 2023, respectively. ESOP compensation expense was $286,262 and $183,364 for the six-month periods ended December 31, 2024 and 2023, respectively. The ESOP shares as of December 31, 2024 and 2023 were as follows: December 31, 2024 December 31, 2023 Allocated shares 385,641 440,801 Committed-to-be-released shares 10,835 11,080 Unreleased shares 200,652 222,565 Total shares held by the ESOP 597,128 674,446 Fair value of unreleased shares $ 6,049,658 $ 4,161,966 The Company may at times be required to repurchase shares at the ESOP participants’ request at the shares’ fair market value. During the three and six months ended December 31, 2024 and 2023, the Company did not repurchase shares previously held by the ESOP. The ESOP allows for eligible participants to take whole share distributions from the Plan on specific dates in accordance with the provision of the Plan. Share distributions from the ESOP during the six months ended December 31, 2024 and 2023 totaled 65,491 and 44,157 shares, respectively.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 1,908,499	$ 1,795,370	$ 3,506,816	$ 2,889,914

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Investment Securities (Tables)

Investment Securities (Tables)	6 Months Ended
	Dec. 31, 2024
Investment Securities [Abstract]
Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities	The cost, gross unrealized gains, gross unrealized losses and fair value of available-for-sale debt securities by major security type at December 31, 2024 and June 30, 2024 are as follows: Gross Gross Amortized Unrealized Unrealized Fair Cost Gains Losses Value December 31, 2024 Certificates of deposit $ 19,028,000 $ — $ — $ 19,028,000 Municipal bonds 1,134,476 5,797 (3,459 ) 1,136,814 U.S. Treasury bills 95,756 3,997 — 99,753 Total investment securities $ 20,258,232 $ 9,794 $ (3,459 ) $ 20,264,567 June 30, 2024 Certificates of deposit $ 17,651,000 $ — $ — $ 17,651,000 Municipal bonds 709,059 5,824 (3,313 ) 711,570 U.S. Treasury bills 510,288 5,773 — 516,061 Total investment securities $ 18,870,347 $ 11,597 $ (3,313 ) $ 18,878,631
Schedule of Contractual Maturities of Available-for-Sale Debt Securities	As of December 31, 2024 and June 30, 2024, the remaining contractual maturities of available-for-sale debt securities were as follows: Years to Maturity Less than One to One Year Five Years Total December 31, 2024 Available-for-sale $ 18,116,028 $ 2,148,539 $ 20,264,567 June 30, 2024 Available-for-sale $ 17,889,582 $ 989,049 $ 18,878,631

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
	Dec. 31, 2024
Net Income Per Share [Abstract]
Schedule of Denominators of the Basic and Diluted Earnings Per Share	The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the six month periods ended December 31: 2024 2023 Numerator: Net income $ 3,506,816 $ 2,889,914 Denominator: Basic EPS: Common shares outstanding, beginning of period 2,733,958 2,702,633 Unearned ESOP shares (211,487 ) (233,646 ) Weighted average common shares issued during the period 29,384 2,523 Weighted average ESOP shares earned during the period 2,767 2,830 Denominator for basic earnings per common shares – Weighted average common shares 2,554,622 2,474,340 Diluted EPS: Common shares outstanding, beginning of period 2,733,958 2,702,633 Unearned ESOP shares (211,487 ) (233,646 ) Weighted average common shares issued during the period 29,384 2,523 Weighted average ESOP shares earned during the period 2,767 2,830 Weighted average dilutive effect of stock options 99,268 18,159 Denominator for diluted earnings per common shares – Weighted average common shares 2,653,890 2,492,499

Stock Based Compensation (Table

Stock Based Compensation (Tables)	6 Months Ended
	Dec. 31, 2024
Stock Based Compensation [Abstract]
Schedule of Weighted Average Assumptions of Option Award	The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the six months ended December 31, 2024 and 2023. December 31, 2024 December 31, 2023 Dividend yield 3.79% 3.63% Company’s expected volatility 33.33% 31.20% Risk-free interest rate 4.35% 4.39% Expected term 5.1 yrs 5.3 yrs Weighted average fair value per share of options granted during the period $ 5.40 $ 4.03
Schedule of Stock Option Activity	The following table summarizes stock option activity during the six months ended December 31, 2024: Employee Stock Option Plans Weighted Number of Weighted Average Shares Average Remaining Aggregate Subject Exercise Contractual Intrinsic to Option Price Term Value Balance at July 1, 2024 322,056 $ 18.41 6.59 Granted 76,500 $ 21.58 9.52 Exercised (62,800 ) $ 17.89 — Forfeited or expired (500 ) $ 16.54 — Outstanding at December 31, 2024 335,256 $ 19.23 6.95 $ 3,661,427 Vested or expected to vest at December 31, 2024 320,083 $ 19.19 6.84 $ 3,507,361 Exercisable at December 31, 2024 180,356 $ 19.26 5.09 $ 1,964,248
Schedule of Changes in Non-Vested Stock Options	The following table summarizes changes in non-vested stock options during the six months ended December 31, 2024: Weighted Number Average of Shares Grant Date Subject Fair Value to Option (per Option) Non-vested at July 1, 2024 147,300 $ 4.15 Granted 76,500 $ 5.40 Vested (68,400 ) $ 4.11 Forfeited or expired (500 ) $ 4.03 Non-vested at December 31, 2024 154,900 $ 4.78

Employee Stock Ownership Plan (

Employee Stock Ownership Plan (Tables)	6 Months Ended
	Dec. 31, 2024
Employee Stock Ownership Plan [Abstract]
Schedule of ESOP Shares	The ESOP shares as of December 31, 2024 and 2023 were as follows: December 31, 2024 December 31, 2023 Allocated shares 385,641 440,801 Committed-to-be-released shares 10,835 11,080 Unreleased shares 200,652 222,565 Total shares held by the ESOP 597,128 674,446 Fair value of unreleased shares $ 6,049,658 $ 4,161,966

Investment Securities - Schedul

Investment Securities - Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities [Line Items]
Amortized Cost	$ 20,258,232	$ 18,870,347
Gross Unrealized Gains	9,794	11,597
Gross Unrealized Losses	(3,459)	(3,313)
Fair Value	20,264,567	18,878,631
Certificates of deposit [Member]
Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities [Line Items]
Amortized Cost	19,028,000	17,651,000
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value	19,028,000	17,651,000
Municipal bonds [Member]
Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities [Line Items]
Amortized Cost	1,134,476	709,059
Gross Unrealized Gains	5,797	5,824
Gross Unrealized Losses	(3,459)	(3,313)
Fair Value	1,136,814	711,570
U.S. Treasury bills [Member]
Schedule of Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value of Available-For-Sale Debt Securities [Line Items]
Amortized Cost	95,756	510,288
Gross Unrealized Gains	3,997	5,773
Gross Unrealized Losses
Fair Value	$ 99,753	$ 516,061

Investment Securities - Sched_2

Investment Securities - Schedule of Contractual Maturities of Available-for-Sale Debt Securities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Schedule of Contractual Maturities of Available-for-Sale Debt Securities [Line Items]
Less than One Year	$ 18,116,028	$ 17,889,582
One to Five Years	2,148,539	989,049
Available-for-sale debt securities	$ 20,264,567	$ 18,878,631

Net Income Per Share (Details)

Net Income Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2023
Net Income Per Share [Abstract]
Options to purchase shares	0	149,531	149,531

Net Income Per Share - Schedule

Net Income Per Share - Schedule of Denominators of the Basic and Diluted Earnings Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Numerator:
Net income (in Dollars)	$ 1,908,499	$ 1,795,370	$ 3,506,816	$ 2,889,914
Basic EPS:
Common shares outstanding, beginning of period	2,733,958	2,702,633	2,733,958	2,702,633
Unearned ESOP shares			(211,487)	(233,646)
Weighted average common shares issued during the period			29,384	2,523
Weighted average ESOP shares earned during the period			2,767	2,830
Denominator for basic earnings per common shares –Weighted average common shares			2,554,622	2,474,340
Diluted EPS:
Common shares outstanding, beginning of period	2,733,958	2,702,633	2,733,958	2,702,633
Unearned ESOP shares			(211,487)	(233,646)
Weighted average common shares issued during the period			29,384	2,523
Weighted average ESOP shares earned during the period			2,767	2,830
Weighted average dilutive effect of stock options			99,268	18,159
Denominator for diluted earnings per common shares – Weighted average common shares	2,707,542	2,499,210	2,653,890	2,492,499

Stock Based Compensation (Detai

Stock Based Compensation (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Stock Based Compensation [Line Item]
Stock-based compensation expense	$ 91,541	$ 75,502	$ 193,033	$ 131,155
Deferred tax benefit			7,814
Unrecognized compensation cost	$ 423,041		$ 423,041
Period in which compensation cost will be recognized			1 year 9 months
Vesting period			2 years
Shares remain available for grant (in Shares)	4,969		4,969
Dividends per share (in Dollars per share)			$ 0.5	$ 0.3
Aggregate intrinsic value of options exercised			$ 668,878	$ 9,482
Non-qualified Stock Options [Member]
Stock Based Compensation [Line Item]
Stock-based compensation expense	$ 8,362	10,290	15,421	18,545
Deferred tax benefit	1,756	$ 2,161	3,238	$ 3,894
Unrecognized compensation cost	37,208		37,208
Incentive Stock Options [Member]
Stock Based Compensation [Line Item]
Unrecognized compensation cost	$ 385,833		$ 385,833
Stock Options [Member]
Stock Based Compensation [Line Item]
Shares exercised options (in Shares)			87,375
Shares outstanding options (in Shares)	307,656		307,656
2017 Plan [Member] | Stock Options [Member]
Stock Based Compensation [Line Item]
Vesting period			2 years
Authorized shares under plan (in Shares)	400,000		400,000
2017 Plan [Member] | Non-Employee Directors [Member]
Stock Based Compensation [Line Item]
Aggregate number of common stock (in Shares)			133,000
2017 Plan [Member] | Non-Employee Directors [Member] | Maximum [Member]
Stock Based Compensation [Line Item]
Aggregate number of common stock (in Shares)			13,300
Percentage of total number of shares subject to options or awards, single fiscal year			33 1/3%
2017 Plan [Member] | Individual Employee [Member] | Maximum [Member]
Stock Based Compensation [Line Item]
Aggregate number of common stock (in Shares)			15,000
2007 Plan [Member] | Restricted Stock Plan [Member]
Stock Based Compensation [Line Item]
Outstanding shares (in Shares)			27,600

Stock Based Compensation - Sche

Stock Based Compensation - Schedule of Weighted Average Assumptions of Option Award (Details) - $ / shares	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Schedule of Weighted Average Assumptions of Option Award [Abstract]
Dividend yield	3.79%	3.63%
Company’s expected volatility	33.33%	31.20%
Risk-free interest rate	4.35%	4.39%
Expected term	5 years 1 month 6 days	5 years 3 months 18 days
Weighted average fair value per share of options granted during the period (in Dollars per share)	$ 5.4	$ 4.03

Stock Based Compensation - Sc_2

Stock Based Compensation - Schedule of Stock Option Activity (Details) - Equity Option [Member]		6 Months Ended
	Jul. 01, 2024 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares
Schedule of Stock Option Activity [Abstract]
Number of Shares Subject to Option, Granted | shares		76,500
Weighted Average Exercise Price, Granted | $ / shares		$ 21.58
Weighted Average Remaining Contractual Term, Granted		9 years 6 months 7 days
Number of Shares Subject to Option, Exercised | shares		(62,800)
Weighted Average Exercise Price, Exercised | $ / shares		$ 17.89
Weighted Average Remaining Contractual Term, Exercised
Number of Shares Subject to Option, Forfeited or expired | shares		(500)
Weighted Average Exercise Price, Forfeited or expired | $ / shares		$ 16.54
Weighted Average Remaining Contractual Term, Forfeited or expired
Number of Shares Subject to Option, Ending | shares	322,056	335,256
Weighted Average Exercise Price, Ending | $ / shares	$ 18.41	$ 19.23
Weighted Average Remaining Contractual Term, Ending	6 years 7 months 2 days	6 years 11 months 12 days
Aggregate Intrinsic Value, Ending | $		$ 3,661,427
Number of Shares Subject to Option, Vested or expected to vest | shares		320,083
Weighted Average Exercise Price, Vested or expected to vest | $ / shares		$ 19.19
Weighted Average Remaining Contractual Term, Vested or expected to vest		6 years 10 months 2 days
Aggregate Intrinsic Value, Vested or expected to vest | $		$ 3,507,361
Number of Shares Subject to Option, Exercisable | shares		180,356
Weighted Average Exercise Price, Exercisable | $ / shares		$ 19.26
Weighted Average Remaining Contractual Term, Exercisable		5 years 1 month 2 days
Aggregate Intrinsic Value, Exercisable | $		$ 1,964,248

Stock Based Compensation - Sc_3

Stock Based Compensation - Schedule of Changes in Non-Vested Stock Options (Details)	6 Months Ended
	Dec. 31, 2024 $ / shares shares
Schedule of Changes in Non-Vested Stock Options [Abstract]
Weighted Number of Shares Subject to Option, Non-vested Beginning | shares	147,300
Average Grant Date Fair Value (per Option), Non-vested Beginning | $ / shares	$ 4.15
Weighted Number of Shares Subject to Option, Granted | shares	76,500
Average Grant Date Fair Value (per Option), Granted | $ / shares	$ 5.4
Weighted Number of Shares Subject to Option, Vested | shares	(68,400)
Average Grant Date Fair Value (per Option), Vested | $ / shares	$ 4.11
Weighted Number of Shares Subject to Option, Forfeited or expired | shares	(500)
Average Grant Date Fair Value (per Option), Forfeited or expired | $ / shares	$ 4.03
Weighted Number of Shares Subject to Option, Non-vested Ending | shares	154,900
Average Grant Date Fair Value (per Option), Non-vested Ending | $ / shares	$ 4.78

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2023
Commitments and Contingencies [Abstract]
Contingent liabilities on outstanding standby letters of credit agreements	$ 0	$ 0
Funding amount	3,400,000	7,400,000
Deferred tax asset	888,032
Total deferred tax asset	4,228,722
Property, plant, and equipment amount	2,311,788	965,392
Accounts payable	11,770	272,560
Termination withdrawal obligation	$ 561,852	772,157
Remaining liability		$ 561,852

Revenue (Details)

Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Revenue [Line Items]
Revenue	$ 13,608,740	$ 10,302,541	$ 24,051,958	$ 18,870,755
Revenue recognized contract liabilities			$ 2,377,108
Contract term			1 year
ASC 606 [Member]
Revenue [Line Items]
Contract liabilities	9,875,627		$ 9,875,627		$ 9,043,422
ASC 606 [Member] | Order or Production Backlog [Member]
Revenue [Line Items]
Intangible assets	$ 120,100,000		$ 120,100,000
Backlog amount to be recognized, 2025	16.60%		16.60%
Backlog amount to be recognized, 2026	37.40%		37.40%
Backlog amount to be recognized, 2027	7.60%		7.60%
Backlog amount to be recognized	38.40%		38.40%
Units Delivered [Member] | ASC 606 [Member]
Revenue [Line Items]
Revenue	$ 9,237,688	8,237,156	$ 17,500,184	14,642,694
Milestones Achieved [Member] | ASC 606 [Member]
Revenue [Line Items]
Revenue	$ 4,371,052	$ 2,065,385	$ 6,551,774	$ 4,228,061

Employee Stock Ownership Plan_2

Employee Stock Ownership Plan (Details) - Employee Stock Ownership Plan [Member]		3 Months Ended		6 Months Ended
	Jun. 30, 2024	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 USD ($) shares
Employee Stock Ownership Plan [Line Items]
Number of hours worked per year to qualify for the plan	1,000
ESOP compensation expense | $		$ 163,067	$ 94,175	$ 286,262	$ 183,364
Shares distributed (in Shares) | shares				65,491	44,157

Employee Stock Ownership Plan -

Employee Stock Ownership Plan - Schedule of ESOP Shares (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Schedule of ESOP Shares [Abstract]
Allocated shares	385,641	440,801
Committed-to-be-released shares	10,835	11,080
Unreleased shares	200,652	222,565
Total shares held by the ESOP	597,128	674,446
Fair value of unreleased shares (in Dollars)	$ 6,049,658	$ 4,161,966